Upcoming Scientific Webinar: Molecular Oncology of Brain Tumors: Translational Advances and Therapeutic Targets
- Nazar Vasyliv
- Feb 2
- 1 min read
Updated: Feb 4
This scientific webinar addresses molecular mechanisms underlying brain tumour development and their translation into targeted and precision therapeutic strategies, with direct relevance to research and clinical practice.
Scientific Programme Highlights
Molecular drivers of high-grade gliomas (EGFR, IDH1/2, BRAF, TP53, H3K27M)
Epigenetic regulation and tumour heterogeneity
Targeted therapy and precision oncology approaches
Synthetic lethality and DNA repair vulnerabilities
Tumour microenvironment and immunotherapy biomarkers
CRISPR, RNAi, and single-cell sequencing in translational research
Liquid biopsy, radiogenomics, and clinical implementation in UK/EU workflows
Live Q&A session included.
Date: 21 February 2026
Time: 09:00–11:30 (GMT, London)
Format: Live Online Webinar
Platform: Microsoft Teams
Presenter:
Mr. Nazar Vasyliv
Scientific CEO, Global Alliance for Neurosurgical & Brain Cancer Research Innovations (GNCRI)
Registration Fees
Standard Academic: £45
Clinician / Industry: £95
Student / Trainee: £20
Optional Certificate: £15
All registration fees support GNCRI’s global brain tumour research initiatives.
Registration
Follow the link to register: https://forms.gle/UHGCMg6AjGnBdWhm9
Payment
Follow the link to proceed with payment: https://www.paypal.com/ncp/payment/WDW2GVD9LKH9U
Access details will be provided after registration.
Complete webinar details:
Comments